Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but there is a paucity of data identifying its therapeutic efficacy. Among 126 potential convalescent plasma donors, the humoral immune response was evaluated using a severe acute respiratory syndrome coronavirus 2 (...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Invest
Главные авторы: Klein, Sabra L., Pekosz, Andrew, Park, Han-Sol, Ursin, Rebecca L., Shapiro, Janna R., Benner, Sarah E., Littlefield, Kirsten, Kumar, Swetha, Naik, Harnish Mukesh, Betenbaugh, Michael J., Shrestha, Ruchee, Wu, Annie A., Hughes, Robert M., Burgess, Imani, Caturegli, Patricio, Laeyendecker, Oliver, Quinn, Thomas C., Sullivan, David, Shoham, Shmuel, Redd, Andrew D., Bloch, Evan M., Casadevall, Arturo, Tobian, Aaron A.R.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598041/
https://ncbi.nlm.nih.gov/pubmed/32764200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI142004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы